The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 594, Issue 1-2, 2006, Pages 181-188

  Lee, Jang Ming ^a   Shun, Chia Tung ^a   Wu, Ming Tsang ^b   Chen, Yun Yen ^c   Yang, Shi Yi ^c   Hung, Hsi I ^a   Chen, Jin Shing ^a   Hsu, Hsau Hsun ^a   Huang, Pei Ming ^a   Kuo, Shuenn Wen ^a   Lee, Yung Chie ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Areca; Drinking; Esophageal cancer; Mutation; Overexpression; p53; Polymorphism; Smoking

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BETEL NUT; CANCER RISK; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; DRINKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ALLELES; ARGININE; CARCINOMA, SQUAMOUS CELL; CODON; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; TUMOR SUPPRESSOR PROTEIN P53;

ARECA; PIPER BETEL;

EID: 31644431671     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2005.09.003     Document Type: Article

References (39)

1. D. Schottenfeld Epidemiology of cancer of the esophagus Semin. Oncol. 11 1984 92 100
2. K.K. Cheng, S.W. Duffy, N.E. Day, and T.H. Lam Oesophageal cancer in never-smokers and never-drinkers Int. J. Cancer 60 1995 820 822
3. J.M. Lee, Y.C. Lee, S.Y. Yang, W.L. Shi, C.J. Lee, S.P. Luh, C.J. Chen, C.Y. Hsieh, and M.T. Wu Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus Int. J. Cancer 89 2000 458 464
4. C.H. Lee, J.M. Lee, D.C. Wu, H.K. Hsu, E.L. Kao, H.L. Huang, T.N. Wang, M.C. Huang, and M.T. Wu Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan Int. J. Cancer 113 2004 475 482
5. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris p53 mutations in human cancers Science 253 1991 49 53
6. Y. Cho, S. Gorina, P.D. Jeffrey, and N.P. Pavletich Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations Science 265 1994 346 355
7. M. Stander, A. Peraud, B. Leroch, and F.W. Kreth Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis Cancer 101 2004 1028 1035
8. S.A. Ahrendt, Y. Hu, M. Buta, M.P. McDermott, N. Benoit, S.C. Yang, L. Wu, and D. Sidransky p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study J. Natl. Cancer Inst. 95 2003 961 970
9. Z.M. Shao, J. Wu, Z.Z. Shen, and M. Nguyen p53 mutation in plasma DNA and its prognostic value in breast cancer patients Clin. Cancer Res. 7 2001 2222 2227
10. E. Okuda, H. Osugi, K. Morimura, N. Takada, M. Takemura, S. Fukushima, M. Higashino, and H. Kinoshita Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group Clin. Cancer Res. 7 2001 600 606
11. G.J. Matlashewski, S. Tuck, D. Pim, P. Lamb, J. Schneider, and L.V. Crawford Primary structure polymorphism at amino acid residue 72 of human p53 Mol. Cell. Biol. 7 1987 961 963
12. A. Storey, M. Thomas, A. Kalita, C. Harwood, D. Gardiol, F. Mantovani, J. Breuer, I.M. Leigh, G. Matlashewski, and L. Banks Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 393 1998 229 234
13. P. Dumont, J.I. Leu, A.C. Della Pietra 3rd, D.L. George, and M. Murphy The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat. Genet. 33 2003 357 365
14. A. Sullivan, N. Syed, M. Gasco, D. Bergamaschi, G. Trigiante, M. Attard, L. Hiller, P.J. Farrell, P. Smith, X. Lu, and T. Crook Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo Oncogene 23 2004 3328 3337
15. M. Thomas, A. Kalita, S. Labrecque, D. Pim, L. Banks, and G. Matlashewski Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol. Cell. Biol. 19 1999 1092 1100
16. M.C. Marin, C.A. Jost, L.A. Brooks, M.S. Irwin, J. O'Nions, J.A. Tidy, N. James, J.M. McGregor, C.A. Harwood, I.G. Yulug, K.H. Vousden, M.J. Allday, B. Gusterson, S. Ikawa, P.W. Hinds, T. Crook, and W.G. Kaelin Jr. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour Nat. Genet. 25 2000 47 54
17. L.L. Hsieh, T.H. Huang, I.H. Chen, C.T. Liao, H.M. Wang, C.H. Lai, S.H. Liou, J.T. Chang, and A.J. Cheng p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan Br. J. Cancer 92 2005 30 35
18. M. Furihata, T. Takeuchi, M. Matsumoto, A. Kurabayashi, Y. Ohtsuki, N. Terao, M. Kuwahara, and T. Shuin p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract Clin. Cancer Res. 8 2002 1192 1195
19. J.A. Reed, L.J. Manahan, C.S. Park, and D.J. Brigati Complete one-hour immunocytochemistry based on capillary action Biotechniques 13 1992 434 443
20. T. Hongyo, G.S. Buzard, D. Palli, C.M. Weghorst, A. Amorosi, M. Galli, N.E. Caporaso, J.F. Fraumeni Jr., and J.M. Rice Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy Cancer Res. 55 1995 2665 2672
21. K. Kawajiri, K. Nakachi, K. Imai, J. Watanabe, and S. Hayashi Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer Carcinogenesis 14 1993 1085 1089
22. X. Jin, X. Wu, J.A. Roth, C.I. Amos, T.M. King, C. Branch, S.E. Honn, and M.R. Spitz Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype Carcinogenesis 16 1995 2205 2208
23. M. Murata, M. Tagawa, M. Kimura, H. Kimura, S. Watanabe, and H. Saisho Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history Carcinogenesis 17 1996 261 264
24. A. Sjalander, R. Birgander, G. Hallmans, S. Cajander, P. Lenner, L. Athlin, G. Beckman, and L. Beckman p53 polymorphisms and haplotypes in breast cancer Carcinogenesis 17 1996 1313 1316
25. M.W. Yu, S.Y. Yang, Y.H. Chiu, Y.C. Chiang, Y.F. Liaw, and C.J. Chen A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers Hepatology 29 1999 697 702
26. D. Pim, and L. Banks p53 polymorphic variants at codon 72 exert different effects on cell cycle progression Int. J. Cancer 108 2004 196 199
27. G. Coggi, S. Bosari, M. Roncalli, D. Graziani, P. Bossi, G. Viale, R. Buffa, S. Ferrero, M. Piazza, S. Blandamura, A. Segalin, L. Bonavina, and A. Peracchia p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations Cancer 79 1997 425 432
28. H. Kato, M. Yoshikawa, T. Miyazaki, M. Nakajima, Y. Fukai, K. Tajima, N. Masuda, K. Tsukada, T. Fukuda, T. Nakajima, and H. Kuwano Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers Cancer Lett. 167 2001 65 72
29. K. Kitamura, H. Saeki, H. Kawaguchi, K. Araki, S. Ohno, H. Kuwano, Y. Maehara, and K. Sugimachi Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer Hepatogastroenterology 47 2000 419 423
30. Y. Shimada, G. Watanabe, S. Yamasaki, M. Maeda, A. Kawabe, J.I. Kaganoi, A. Itami, M. Fukumoto, Y. Kanda, and M. Imamura Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity Eur. J. Cancer 36 2000 987 993
31. A. Kanamoto, H. Kato, Y. Tachimori, H. Watanabe, Y. Nakanishi, H. Kondo, H. Yamaguchi, T. Gotoda, K. Muro, and Y. Matsumura No prognostic significance of p53 expression in esophageal squamous cell carcinoma J. Surg. Oncol. 72 1999 94 98
32. F.G. Duhaylongsod, M.R. Gottfried, J.D. Iglehart, A.L. Vaughn, and W.G. Wolfe The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus Ann. Surg. 221 1995 677 683 discussion 683-674
33. J.J. Yu, A. Bicher, Y.K. Ma, F. Bostick-Bruton, and E. Reed Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues Cancer Lett. 151 2000 127 132
34. M.T. Wu, Y.C. Lee, C.J. Chen, P.W. Yang, C.J. Lee, D.C. Wu, H.K. Hsu, C.K. Ho, E.L. Kao, and J.M. Lee Risk of betel chewing for oesophageal cancer in Taiwan Br. J. Cancer 85 2001 658 660
35. T.W. Rice, J.R. Goldblum, G.W. Falk, R.R. Tubbs, T.J. Kirby, and G. Casey p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma J. Thorac. Cardiovasc. Surg. 108 1994 1132 1137
36. J.F. Flejou, F. Paraf, F. Potet, F. Muzeau, F. Fekete, and D. Henin p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significance Histopathology 24 1994 487 489
37. S. Sjogren, M. Inganas, T. Norberg, A. Lindgren, H. Nordgren, L. Holmberg, and J. Bergh The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry J. Natl. Cancer Inst. 88 1996 173 182
38. A.G. Casson, T. Mukhopadhyay, K.R. Cleary, J.Y. Ro, B. Levin, and J.A. Roth p53 gene mutations in Barrett's epithelium and esophageal cancer Cancer Res. 51 1991 4495 4499
39. Japanese Committee for Registration of Esophageal Carcinoma A proposal for a new TNM classification of esophageal carcinoma Jpn. J. Clin. Oncol. 15 1985 625 636